Why cybersecurity is important for FDA approval of medical devices
The medical technology industry is moving faster than ever. Connected devices, cloud-enabled diagnostics, AI-powered imaging systems, wearable monitors, and software as a medical device (SaMD) are transforming patient care. But with innovation comes responsibility: every connected product creates potential cybersecurity risk.
Today, cybersecurity is no longer a “nice to have” for medical device manufacturers—it is a core requirement for regulatory success. If your MedTech company wants a smooth path to U.S. market entry, cybersecurity readiness is essential for successful approval from U.S. Food and Drug Administration.
Cybersecurity Has Become a Safety Issue
Historically, cybersecurity was viewed as an IT concern. In MedTech, it is now directly tied to patient safety.
If a hospital infusion pump is hacked, medication delivery could be altered. If imaging systems are compromised, diagnoses may be delayed. If patient monitoring devices go offline, clinicians may lose visibility into critical conditions.
For regulators, these are not hypothetical technology problems—they are real safety and effectiveness concerns. That means cybersecurity is now inseparable from product quality, risk management, and clinical reliability.
FDA Expectations Have Increased
The U.S. Food and Drug Administration has significantly expanded its expectations for cybersecurity in recent years, especially for connected medical devices.
Manufacturers are increasingly expected to demonstrate:
- Secure product design from the beginning
- Risk-based threat modeling
- Software bill of materials (SBOM) transparency
- Vulnerability management processes
- Secure update and patching capabilities
- Access control and authentication safeguards
- Postmarket monitoring plans
- Documentation proving cybersecurity controls were validated
Cybersecurity can no longer be bolted on at the end of development. It must be embedded throughout the product lifecycle.
Poor Cybersecurity Can Delay Approval
Many MedTech teams underestimate how often submissions are slowed by weak cybersecurity documentation or immature controls.
Common reasons for delay include:
Incomplete Risk Assessments
If a company cannot clearly identify threats, attack surfaces, and mitigations, reviewers may request additional information.
Missing Security Testing Evidence
Penetration testing, secure code reviews, and verification activities are often expected for connected products. Without evidence, confidence drops.
Weak Software Supply Chain Controls
Third-party components and open-source libraries introduce risk. If these dependencies are not tracked or managed, submissions may stall.
No Patching Strategy
Connected devices require a plan for updates. Regulators want confidence that vulnerabilities can be remediated safely after launch.
Every additional question from regulators can add weeks or months to the approval timeline.
Cybersecurity Accelerates Commercial Success Too
Strong cybersecurity does more than help with approval—it strengthens your commercial position.
Hospitals, health systems, and procurement teams increasingly evaluate security before purchasing devices. Many now require vendor risk reviews, questionnaires, and architecture discussions before signing contracts.
A product that passes regulatory review but fails hospital security review can still lose in the market.
Companies with mature cybersecurity programs often benefit from:
- Faster customer procurement cycles
- Greater trust with providers
- Reduced incident risk
- Stronger brand reputation
- Easier expansion into enterprise health systems
- Better readiness for global regulations
Cybersecurity Should Start Early
The most successful MedTech companies treat cybersecurity as an early design discipline, not a late compliance task.
Best practices include:
Build Security Into Design Controls
Integrate cybersecurity requirements into product requirements, architecture reviews, and verification planning.
Align With Risk Management
Coordinate security risk processes with standards like International Organization for Standardization ISO 14971.
Create Clear Documentation
Regulatory success depends on evidence. Maintain organized records for architecture, testing, vulnerabilities, and remediation decisions.
Prepare for Postmarket Operations
Cybersecurity continues after launch. Have processes for monitoring threats, issuing patches, and communicating with customers.
Cybersecurity Is a Business Enabler
Many executives still ask, “How much cybersecurity do we need?”
The better question is: “How important is speed to approval, market trust, and long-term growth?”
Cybersecurity is no longer just defensive spending. In MedTech, it is a strategic enabler that supports:
- Regulatory approval
- Product safety
- Revenue growth
- Customer confidence
- Long-term enterprise value
Final Thoughts
If your medical device connects to software, networks, cloud systems, or patient data, cybersecurity is part of your product—not separate from it.
For MedTech innovators seeking successful U.S. Food and Drug Administration approval, the companies that win will be the ones that treat cybersecurity as foundational from day one.
The future of healthcare technology is connected. That means the future of MedTech success is secure.
